Abstract A050: Cdk5 disruption attenuates tumor PD-L1 expression via regulation of IFN-γ signaling components and promotes antitumor immunity

  • Rodney D. Dorand Jr., Joseph Nthale, Jay T. Myers, Deborah S. Barkauskas, Stefanie Avril, Steven M. Chirieleison, Tej K. Pareek, Derek W. Abbott, Duncan S. Stearns, John J. Letterio, Alex Y. Huang, Agne Petrosiute
  • Cancer Immunology Research, October 2016, American Association for Cancer Research (AACR)
  • DOI: 10.1158/2326-6066.imm2016-a050

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1158/2326-6066.imm2016-a050

The following have contributed to this page: Alex Huang